NRXP Stock Analysis: Buy, Sell, or Hold?
NRXP - NRX Pharmaceuticals, Inc. Common Stock
$3.15
0.03 (0.96%)
▲
5d:
-16.0%
30d:
-18.39%
90d:
+5.7%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 17, 2026
13d
Get Alerted When NRXP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NRXP is down 16.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NRXP is down 16.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.01
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.35
27.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NRXP is currently trading at $3.15, which is considered oversold relative to its 30-day fair value range of $3.55 to $4.29. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.3) compared to its historical average (10.0). Remarkably, the market is currently pricing in an annual earnings decline of 14.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NRXP is in a strong uptrend. Immediate support is located at $2.82, while resistance sits at $4.64.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $42.00 (+1233.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NRXP is in a strong uptrend. Immediate support is located at $2.82, while resistance sits at $4.64.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $42.00 (+1233.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.55 -
$4.29
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding NRXP? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1233.3% below Wall St target ($42.00)
- WARNING: Recommendation downgraded due to -16.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$3.55 -
$4.29
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.82
Resistance Level
$4.64
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.30
Wall Street Target
$42.00
(+1233.3%)
Valuation Discount vs History
-14.4% cheaper
PE vs Historical
6.3 vs 10.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-14.4%
(market-implied from PE analysis)
1-Year Target
$2.83
(-10%)
2-Year Target
$2.55
(-19%)
3-Year Target
$2.30
(-27%)
3-Yr Target (if PE normalizes)
(PE: 6→10)
$3.65
(+16%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.3 to 10.0
Stabilization Target:
$5.00
(+58.7%)
PE Expansion Potential:
+58.7%
Share & Embed Analysis
Last updated: August 03, 2026 1:53 AM ET
Data refreshes hourly during market hours. Next update: 2:53 AM
Data refreshes hourly during market hours. Next update: 2:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRXP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$87 | 53 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 47 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$557 | 49 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 47 HOLD |
Advanced NRXP Option Strategies
Professional options setups generated by AI based on today's NRXP price and gamma walls.
